Company Filing History:
1 out of 4,450 
1 out of 232 
1 out of 49 
Years Active: 2025
Title: Warren Viricel: Innovator in Antibody Drug Conjugates
Introduction
Warren Viricel is a notable inventor based in Sainte Consorce, France. He has made significant contributions to the field of cancer treatment through his innovative work on antibody drug conjugates (ADCs). His research focuses on developing targeted therapies that can improve patient outcomes.
Latest Patents
Warren Viricel holds 1 patent for an antibody drug conjugate targeting Nectin 4, which comprises an exatecan payload. This patent outlines the use of Nectin-4 ADCs in pharmaceutical compositions and methods for treating cancer. His work represents a promising advancement in targeted cancer therapies.
Career Highlights
Throughout his career, Warren has worked with prominent organizations, including Eli Lilly and Company and Université D'Aix-Marseille. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Warren has collaborated with notable colleagues such as Jacobus Petrus Maria Elands and Joanna Fares. These partnerships have further enriched his research and development efforts in the area of antibody drug conjugates.
Conclusion
Warren Viricel's innovative work in the field of antibody drug conjugates highlights his commitment to advancing cancer treatment. His contributions are paving the way for more effective therapies that can significantly impact patient care.